IRIS International (IRIS) Posts Q3 EPS of $0.11; Maintains Guidance
More News related to IRIS
- IRIS International to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009
- IRIS International's Sample Processing Division Enters Veterinary Ova and Parasite Detection Market With New Novel Sample Processing Kit
- IRIS International Names Lawrence J. Blecka, Ph.D., as Vice President, Research and Development of Iris Diagnostics Business Unit
- IRIS Int (IRIS) Posts Q3 Loss of $0.06, Beats by 9c; Guides FY09
- IRIS International (IRIS) Tops Q3 EPS by 1c; Maintains FY Guidance
More News related to Earnings
- Hoku Scientific (HOKU) Amends Poly Deal with Jinko Solar
- American International Group (AIG), Greenberg and Smith Settle Disputes
- Heska (HSKA) Announces Agreements with Roche for Blood Gas Product Supply/Affiliated Consumables
- AIG, Greenberg and Smith to settle all disputes
- DryShips (DRYS) Announces Exercise of Over-Allotment Option by Underwriters, Closes Convertible Senior Notes Offering for Net Proceeds of $448M
IRIS International Inc. (NASDAQ: IRIS) reports Q3 EPS of $0.11, 1 cent better than the analyst estimate of $0.10. Revenue for the quarter was $22.19 million, which compares to the estimate of $23.37 million.
Maintains outlook for revenues of $94 - $96 million, and an EPS of $0.40 - $0.42.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
